Cisplatin-Based Chemotherapy versus Cetuximab in Concurrent Chemoradiotherapy for Locally Advanced Head and Neck Cancer Treatment

Background and Purpose. This study aimed to analyze survival, clinical responses, compliance, and adverse effects in locally advanced head and neck cancer (LAHNC) patients treated with split-dose cisplatin-based concurrent chemoradiation therapy (SD-CCRT) or cetuximab with concurrent radiation thera...

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, Ming-Hung, Wang, Ling-Wei, Lu, Hsueh-Ju, Chu, Pen-Yuan, Tai, Shyh-Kuan, Lee, Tsung-Lun, Chen, Ming-Huang, Yang, Muh-Hwa, Chang, Peter Mu-Hsin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2014
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4109223/
https://www.ncbi.nlm.nih.gov/pubmed/25110705
http://dx.doi.org/10.1155/2014/904341

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4109223/
https://www.ncbi.nlm.nih.gov/pubmed/25110705
http://dx.doi.org/10.1155/2014/904341

Ejemplares similares